IM-133N - A Useful Herbal Combination for Eradicating Disease-triggering Pathogens in Mice via Immunotherapeutic Mechanisms
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The present study was undertaken to evaluate the immunomodulatory (IM) activity of IM-133N, a herbal combination in various immunotherapeutic experimental models. Methods: The IM activity of IM-133N was evaluated against three experimental models namely, effect of IM- 133N against Escherichia coli (E. coli)-induced abdominal sepsis in mice, and carbon clearance test was performed in Wistar albino rats to evaluated the phagocytic potential of IM-133N, in addition IM-133N was evaluated for its immunoglobulin enhancing potential in rats, where the immunoglobulin levels were measured by zinc sulphate turbity (ZST) test. Further, IM-133N was subjected for detailed liquid chromatography-mass spectrometry (LC-MS)/MS analysis to identify the probable active constituents present in it. Results: The findings of the present study has demonstrated very promising IM property of IM-133N in all the experimental models. Briefly, pretreatment with IM-133N at 125, 250, 500 and 1,000 mg/kg, p.o. doses had protected the mice against E. coli-induced abdominal sepsis and mortality, further the effect of IM- 133N was found to be significant and dose-dependent. In support of this, in another study administration of IM-133N showed a significant and dose-dependent increase in serum immunoglobulin levels, estimated by ZST test. In line with the above findings, in the carbon clearance test the low doses (125 and 250 mg/ kg, p.o.) of IM-133N increased the rate of carbon clearance, whereas the higher doses (500 and 1,000 mg/kg, p.o.) did not sustain the response, and saturation effect was considered as one of the possible reason for futility of higher doses for IM-133N. In addition, A detailed LC-MS/MS analysis of IM-133N showed 17 bioactive phytochemical constituents: namely, apigenin, chaulmoogric acid, mesquitol, quercetin, symphoxanthone, salireposide, β-sitosterol, nonaeicosanol, β-amyrin, betulic acid, oleanolic acid, symplososide, symponoside, symploveroside, symplocomoside, symconoside A and locoracemoside B. Conclusion: These findings suggest that IM-133N possesses significant IM activity and, hence, could be useful for eradicating opportunistic disease-triggering pathogens via immunotherapeutic mechanisms. The findings also suggest IM-133N may also useful in other immunity disorders.
Abstract
Objectives: The present study was undertaken to evaluate the immunomodulatory (IM) activity of IM-133N, a herbal combination in various immunotherapeutic experimental models. Methods: The IM activity of IM-133N was evaluated against three experimental models namely, effect of IM- 133N against Escherichia coli (E. coli)-induced abdominal sepsis in mice, and carbon clearance test was performed in Wistar albino rats to evaluated the phagocytic potential of IM-133N, in addition IM-133N was evaluated for its immunoglobulin enhancing potential in rats, where the immunoglobulin levels were measured by zinc sulphate turbity (ZST) test. Further, IM-133N was subjected for detailed liquid chromatography-mass spectrometry (LC-MS)/MS analysis to identify the probable active constituents present in it. Results: The findings of the present study has demonstrated very promising IM property of IM-133N in all the experimental models. Briefly, pretreatment with IM-133N at 125, 250, 500 and 1,000 mg/kg, p.o. doses had protected the mice against E. coli-induced abdominal sepsis and mortality, further the effect of IM- 133N was found to be significant and dose-dependent. In support of this, in another study administration of IM-133N showed a significant and dose-dependent increase in serum immunoglobulin levels, estimated by ZST test. In line with the above findings, in the carbon clearance test the low doses (125 and 250 mg/ kg, p.o.) of IM-133N increased the rate of carbon clearance, whereas the higher doses (500 and 1,000 mg/kg, p.o.) did not sustain the response, and saturation effect was considered as one of the possible reason for futility of higher doses for IM-133N. In addition, A detailed LC-MS/MS analysis of IM-133N showed 17 bioactive phytochemical constituents: namely, apigenin, chaulmoogric acid, mesquitol, quercetin, symphoxanthone, salireposide, β-sitosterol, nonaeicosanol, β-amyrin, betulic acid, oleanolic acid, symplososide, symponoside, symploveroside, symplocomoside, symconoside A and locoracemoside B. Conclusion: These findings suggest that IM-133N possesses significant IM activity and, hence, could be useful for eradicating opportunistic disease-triggering pathogens via immunotherapeutic mechanisms. The findings also suggest IM-133N may also useful in other immunity disorders.
참고문헌 (27)
- Chahar MK, "In-vivo antioxidant and immunomodulatory activity of mesuol isolated from Mesua ferrea L. seed oil", Int Immunopharmacol, 3(4), pp.386~391 (2012)
- Kumar D, "A review of immunomodulators in the Indian traditional health care system", J Microbiol Immunol Infect, 45(3), pp.165~184 (2012)
- Sagrawat H, "Immunomodulatory plants: a phytopharmacological review", Pharmacog Rev, 1, pp.248~260 (2007)
- Wichers H, "Immunomodulation by food : promising concept for mitigating allergic disease?", Anal Bioanal Chem, 395(1), pp.37~45 (2009)
- Aranha I, "Immunostimulatory properties of the major protein from the stem of the Ayurvedic medicinal herb, guduchi(Tinospora cordifolia)", J Ethnopharmacol, 139(2), pp.366~372 (2012)
- Wang J, "Targeting potassium channels Kv1.3 and KC a 3.1: routes to selective immunomodulators in autoimmune disorder treatment", Pharmacotherapy, 33(5), pp.515~528 (2013)
- Tzianabos AO, "Polysaccharide immunomodulators as therapeutic agents : structural aspects and biologic function", Clin Microbiol Rev, 13(4), pp.523~533 (2000)
- Makare N, "Immunomodulatory activity of alcoholic extract of Mangifera indica L. in mice", J Ethanopharmacol, 78(2-3), pp.133~137 (2001)
- Mitra SK, "Immunoprotective effect of IM 133", Int J Immunopharmacol, 21(2), pp.115~120 (1999)
- Miyamoto M, "Tumor-specificity and radical scavenging activity of poly-herbal formula", Anticancer Res, 22(2), pp.1217~1223 (2002)
- Aschaffenburg R, "The nutritive value of colostrums for the calf", British J Nutrition, 3(2-3), pp.200~204 (1949)
- McEwan AD, "Turbidity test for the estimation of immune globulin levels in neonatal calf serum", Clin Chim Acta, 27(1), pp.155~163 (1970)
- Rao CS, "Immunotherapeutic modification by an ayurvedic formulation septilin", Indian J Exp Biol, 32(8), pp.553~558 (1994)
- Daswani BR, "Immunomodulatory activity of septilin, a polyherbal preparation", Phytother Res, 16(2), pp.162~165 (2002)
- Mehrzad J, "Stressed (acute) mice display neuroimmunodysregulation and defective innate immune response against coliform infection", Int Immunopharmacol, 28(1), pp.168~174 (2015)
- Bermúdez RC, "Immunomodulating effects of hot-water extract from Plurotus ostereatus mycelium on cyclophosphamide treated mice", Micol Aplicada Int, 15(1), pp.7~13 (2003)
- Das UN, "Current advances in sepsis and septic shock with particular emphasis on the role of insulin", Med Sci Monit, 9(8), pp.181~192 (2003)
- Varma RS, "IM-133N modulates cytokine secretion by RAW264.7 and THP-1 cells", J Immunotoxicol, 13(2), pp.217~225 (2016)
- Tiwari U, "Immunomodulatory effect of aqueous extract of Tridax procumbens in experimental animals", J Ethanopharmacol, 92(1), pp.113~119 (2004)
- Gokhlale AB, "Investigation in the immuno-modulatory activity of Argyreia speciosa", J Ethanopharmacol, 84(1), pp.109~114 (2003)
- Raphael TJ, "Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system", Phytomedicine, 10(6-7), pp.483~489 (2003)
- Belapurkar P, "Immunomodulatory effects of Triphala and its individual constituents : a review", Indian J Pharm Sci, 76(6), pp.467~475 (2014)
- Yun Y, "Immunomodulatory activity of betulinic acid by producing pro-inflammatory cytokines and activation of macrophages", Arch Pharm Res, 26(12), pp.1087~1095 (2003)
- Fraile L, "Immunomodulatory properties of beta-sitosterol in pig immune responses", Int Immunopharmacol, 13(3), pp.316~321 (2012)
- Gulati K, "Immunomodulatory indian medicinal plants", J Nat Remedies, 2(2), pp.121~131 (2002)
- Kateřina Valentová, "(Anti)mutagenic and immunomodulatory properties of quercetin glycosides", Journal of the Science of Food and Agriculture, 96(5), pp.1492~1499 (2016), Wiley-Blackwell[DOI]
- Sameksha K, "Immunomodulatory activity of phytoconstituent of Melissa officinalis", Der Pharmacia Lettre, 5(1), pp.141~145 (2013)